Tag: Eisai

🔹 In Tech news this week… SoftBank and Oracle forge strategic alliance to advance Japan’s AI and sovereign…

Eisai Co., Ltd. and Biogen Inc. LEQEMBI® IQLIK™ (lecanemab-irmb) is now available in the U.S. It’s a subcutaneous…

🔹 In Tech news this week… Panasonic IS launches Indigo River on Microsoft Teams to streamline communication and…

Eisai Co., Ltd. and Biogen Inc. have started a rolling supplemental Biologics License Application (sBLA) with the U.S.…

Eisai Co., Ltd. announced that it has received orphan drug designation for anticancer agent the EZH2 inhibitor tazemetostat…

Eisai Co., Ltd. and Biogen Inc. shared that LEQEMBI (lecanemab), an anti-amyloid beta monoclonal antibody, launched in Austria…

Eisai Co., Ltd. DAYVIGO® (lemborexant) has been approved in China, where it’s sold as “达卫可®.” The drug will…

Eisai Co., Ltd. announced that it has signed a license agreement with SciClone Pharmaceuticals Limited to grant exclusive…